Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Vaccinia virus Ab:ACnc:Pt:Ser:Qn

Known as: VACV Ac Ser-aCnc, ?? ???? ??:????:????:??:??, Çiçek virüsü Ab:SçKons:Zml?:Ser:Kant 
 
National Institutes of Health

Related topics

Related topics

6 relations
ACncAntibodiesMicrobiology procedureSerum
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Inhibition of DAI-dependent necroptosis by the Z-DNA binding domain of the vaccinia virus innate immune evasion protein, E3
Significance The host interferon system is a potent antiviral system, responsible for protecting vertebrate organisms against… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2015
2015
Recombinant vaccinia virus GLV-1h68 is a promising oncolytic vector in the treatment of cholangiocarcinoma
Although early stage cholangiocarcinoma (CC) can be cured by surgical extirpation, the options for treatment of advanced stage CC… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2013
2013
Single-virus fusion experiments reveal proton influx into vaccinia virions and hemifusion lag times.
Recent studies have revealed new insights into the endocytosis of vaccinia virus (VACV). However, the mechanism of fusion between… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2012
2012
A selective Seoul-Fluor-based bioprobe, SfBP, for vaccinia H1-related phosphatase--a dual-specific protein tyrosine phosphatase.
We report a Seoul-Fluor-based bioprobe, SfBP, for selective monitoring of protein tyrosine phosphatases (PTPs). A rational design… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
2011
2011
A single cidofovir treatment rescues animals at progressive stages of lethal orthopoxvirus disease
BackgroundIn an event of a smallpox outbreak in humans, the window for efficacious treatment by vaccination with vaccinia viruses… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
2010
2010
Modified vaccinia Ankara expressing survivin combined with gemcitabine generates specific antitumor effects in a murine pancreatic carcinoma model
Survivin is overexpressed by 70–80% of pancreatic cancers, and is associated with resistance to chemotherapy and a poor prognosis… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 4
  • figure 3
2010
2010
Interaction of Poxvirus Intracellular Mature Virion Proteins with the TPR Domain of Kinesin Light Chain in Live Infected Cells Revealed by Two-Photon-Induced Fluorescence Resonance Energy Transfer…
ABSTRACT Using two-photon-induced fluorescence lifetime imaging microscopy, we corroborate an interaction (previously… Expand
  • table 1
  • table 2
  • figure 1
  • figure 3
  • figure 2
2008
2008
Real-time PCR assay to identify variants of Vaccinia virus: implications for the diagnosis of bovine vaccinia in Brazil.
Naturally occurring infections of Vaccinia virus (VACV) have been recognized in Brazil during the past 10 years. Human Brazilian… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
2007
2007
Dose-response studies for the elicitation of CD8 T cells by a DNA vaccine, used alone or as the prime for a modified vaccinia Ankara boost.
Here, we conduct dose-response studies in mice for the elicitation of CD8 T cells by a DNA vaccine that expresses HIV Gag. For… Expand
2005
2005
Vaccinia virus intracellular enveloped virions move to the cell periphery on microtubules in the absence of the A36R protein.
Vaccinia virus (VACV) intracellular enveloped virus (IEV) particles are transported to the cell periphery on microtubules where… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE